What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel.
Thienopyridines are a class of drug targeting the platelet adenosine diphosphate 2 receptor. They have been shown to significantly reduce platelet activity exerting an important role in those clinical settings in which such an effect is beneficial. Ticlopidine was first to be introduced several year...
Những tác giả chính: | Testa, L, Bhindi, R, Van Gaal, W, Latini, R, Pizzocri, S, Lanotte, S, Biondi Zoccai, G, Valgimigli, M, Laudisa, M, Brambilla, N, Banning, A, Bedogni, F |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2010
|
Những quyển sách tương tự
-
Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis.
Bằng: Testa, L, et al.
Được phát hành: (2010) -
Current Concepts on Antiplatelet Therapy: Focus on the Novel Thienopyridine and Non-Thienopyridine Agents
Bằng: L. Testa, et al.
Được phát hành: (2010-01-01) -
Use of prasugrel in patients with clopidogrel hypersensitivity
Bằng: Aparna Joshi, et al.
Được phát hành: (2022-01-01) -
Interaction between statins and clopidogrel: is there anything clinically relevant?
Bằng: Bhindi, R, et al.
Được phát hành: (2008) -
Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition.
Bằng: Testa, L, et al.
Được phát hành: (2009)